122 related articles for article (PubMed ID: 15381393)
21. Determination of soluble fibrin monomer complexes by adsorption on immobilized fibrinogen.
Stemberger AW; Hörmann H
Thromb Haemost; 1978 Jun; 39(3):574-81. PubMed ID: 568324
[TBL] [Abstract][Full Text] [Related]
22. Detection of soluble fibrin monomer complexes. Comparison of a haemagglutination assay with the ethanol gelation test.
Oehler G; Klaus H; Stötzer KE; Spanuth E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):278-83. PubMed ID: 2465216
[TBL] [Abstract][Full Text] [Related]
23. [Relationship between the plasma levels of soluble fibrin monomer and the formation of soluble fibrin monomer complex (SFMC)].
Okajima K; Okabe H; Kumagai T; Yang WP; Maeda M; Miyagawa S; Watanabe E; Yoshimi K; Koga S; Takatsuki K
Rinsho Byori; 1989 Apr; 37(4):411-5. PubMed ID: 2787429
[No Abstract] [Full Text] [Related]
24. [Plasma levels of soluble fibrin in patients with disseminated intravascular coagulation].
Wada H; Takeda Y; Sakakura M; Watanabe R; Nakazaki T; Shiku H; Nishioka J; Nobori T
Rinsho Byori; 2001 Aug; 49(8):813-7. PubMed ID: 11573293
[TBL] [Abstract][Full Text] [Related]
25. Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3.
Gailit J; Clarke C; Newman D; Tonnesen MG; Mosesson MW; Clark RA
Exp Cell Res; 1997 Apr; 232(1):118-26. PubMed ID: 9141628
[TBL] [Abstract][Full Text] [Related]
26. Content of soluble fibrin in plasma of patients after myocardial infarction, with carcinomas and consumption coagulopathy.
Reinicke R; Matthias FR; Lasch HG
Thromb Res; 1977 Sep; 11(3):365-75. PubMed ID: 918902
[No Abstract] [Full Text] [Related]
27. Human fibroblast adhesion to fibrinogen.
Farrell DH; al-Mondhiry HA
Biochemistry; 1997 Feb; 36(5):1123-8. PubMed ID: 9033403
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of the interaction of desAABB-fibrin monomer with immobilized fibrinogen.
Chtcheglova LA; Vogel M; Gruber HJ; Dietler G; Haeberli A
Biopolymers; 2006 Sep; 83(1):69-82. PubMed ID: 16639743
[TBL] [Abstract][Full Text] [Related]
29. Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides.
Chang MC; Wang BR; Huang TF
Thromb Haemost; 1995 Aug; 74(2):764-9. PubMed ID: 8585019
[TBL] [Abstract][Full Text] [Related]
30. Soluble fibrin consists of fibrin oligomers of heterogeneous distribution.
Rötker J; Preissner KT; Müller-Berghaus G
Eur J Biochem; 1986 Mar; 155(3):583-8. PubMed ID: 3956500
[TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
Thiel W; Delvos U; Müller-Berghaus G
Thromb Haemost; 1985 Aug; 54(2):533-8. PubMed ID: 4082091
[TBL] [Abstract][Full Text] [Related]
32. Latex immunoturbidimetric assay for soluble fibrin complex.
Hamano A; Umeda M; Ueno Y; Tanaka S; Mimuro J; Sakata Y
Clin Chem; 2005 Jan; 51(1):183-8. PubMed ID: 15514091
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a mode of specific binding of fibrin monomer through its amino-terminal domain by macrophages and macrophage cell-lines.
Shainoff JR; Stearns DJ; DiBello PM; Hishikawa-Itoh Y
Thromb Haemost; 1990 Apr; 63(2):193-203. PubMed ID: 2163552
[TBL] [Abstract][Full Text] [Related]
34. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
[TBL] [Abstract][Full Text] [Related]
35. The effect of the fibrinogen concentration and the leukocyte count on intravascular fibrin deposition from soluble fibrin monomer complexes.
Gurewich V; Lipinski B; Hyde E
Thromb Haemost; 1976 Dec; 36(3):605-14. PubMed ID: 1037154
[TBL] [Abstract][Full Text] [Related]
36. Disseminated intravascular coagulation (DIC).
Mammen EF
Clin Lab Sci; 2000; 13(4):239-45. PubMed ID: 11586511
[TBL] [Abstract][Full Text] [Related]
37. Analysis of soluble fibrin complexes by agarose gel chromatography and protamine sulfate gelation.
Latallo ZS; Mattler LE; Bang NU; Hansen MS; Chang ML
Biochim Biophys Acta; 1976 Jan; 420(1):69-80. PubMed ID: 1247582
[TBL] [Abstract][Full Text] [Related]
38. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of platelet adhesion to fibrin(ogen) in flowing whole blood by Arg-Gly-Asp and fibrinogen gamma-chain carboxy terminal peptides.
Hantgan RR; Endenburg SC; Cavero I; Marguerie G; Uzan A; Sixma JJ; de Groot PG
Thromb Haemost; 1992 Dec; 68(6):694-700. PubMed ID: 1287884
[TBL] [Abstract][Full Text] [Related]
40. Streptococcus gordonii FSS2 Challisin affects fibrin clot formation by digestion of the αC region and cleavage of the N -terminal region of the Bβ chains of fibrinogen.
Harty DW; Farahani RM; Simonian MR; Hunter L; Hunter N
Thromb Haemost; 2012 Aug; 108(2):236-46. PubMed ID: 22552295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
